Graft-vs-host disease (GVHD) remains a major cause of morbidity and mortality after
allogeneic stem cell transplantation. GVHD was first described by Barnes and Mole1 as a …

Graft‐versus‐host disease (GvHD) is a common and often serious complication of
hematopoietic stem cell transplantation. There are two major forms of GvHD: an acute form …

Acute and chronic graft-versus-host disease (GVHD) continue to be major limitations to
successful hematopoietic stem cell transplantation. A variety of different immunosuppressive …

Background Extracorporeal photopheresis (ECP) has been used successfully to treat severe
steroid‐refractory acute and chronic graft‐versus‐host disease (aGVHD, cGVHD) since the …

Chronic graft-versus-host disease (GVHD) is a serious and life-threatening complication
after allogeneic hematopoietic stem cell transplantation. Cutaneous manifestations such as …

Background: Chronic graft-versus-host disease (cGVHD) can arise frequently as a late
complication after allogeneic hematopoietic cell transplantation. Patients with extensive …

We conducted a retrospective analysis of all allogeneic stem cell transplantation (ASCT)
patients started on extracorporeal photopheresis (ECP) for the management of steroid …

Background: Extracorporeal photopheresis (ECP) is a second-line therapy for steroid-
refractory chronic graft-versus-host disease (cGVHD). Objective: We describe the long-term …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

Chronic graft-versus-host disease (CGVHD) presents an array of complex dermatological
manifestations. This article describes the pathogenesis, clinical presentation, diagnosis …